Zorm · Life Sciences

The science is the story.
We build the machine that tells it.

Marketing, websites and data funnels for growth-mode biotech — preclinical through clinical, platforms, tools and services. Built by a team that ships software for a living, and written for the science-literate buyer.

Trusted by serious buyers · adjacent work incl. Department of Defense IAT Insurance Group Yardi
Lumen Labs Illustrative campaign

Know your
baseline. Own it.

LUMEN-9 — the at-home cellular-health panel. Results in days, science in plain English.

Join the waitlist
LUMEN –9–
FIG. 00 — launch creative on top, the Zorm data spine underneath. LUMEN-9 is a Zorm concept, not a real product; no health claims made. The machine is real.
Fig. 01 · The audience problem

Everything you publish is read four ways at once.

A press release, a pipeline update, a conference abstract, the website itself — each artifact is scored simultaneously by four different readers with four different questions. Generic agencies flatten this into hype. Internal teams drown it in jargon. The work is holding all four at once.

Reader 01

Scientists & KOLs

Is this rigorous?

One overstated claim and credibility is gone in the only community that talks to itself daily.

Reader 02

Investors

Is this momentum?

Milestones, runway and inflection points — legible in ninety seconds, defensible in diligence.

Reader 03

Pharma BD & partners

Does this fit our pipeline?

Mechanism, stage and data package findable without a meeting.

Reader 04

Talent

Is this a serious place to build a career?

The site is the first interview — scientists check it before they reply to the recruiter.

Fig. 02 · Why it breaks

Three failure modes we see in growth-mode biotech.

Failure 01

Episodic marketing

The site gets rebuilt at each raise, goes quiet in between, and reads eighteen months stale exactly when a partner finally looks. Diligence rewards continuous signal, not bursts.

Failure 02

The jargon–hype trap

Copy either assumes a PhD or promises a miracle. Both lose: one reader bounces, the other — the scientist — quietly downgrades you.

Failure 03

Fragmented data

CRM, email tool, event scans, webinar platform and website all disconnected. Nobody can answer the only question that matters: which channel produced the partner meeting?

Fig. 03 · The offer

Six things we build for life-science teams.

Scoped as fixed-price engagements, delivered by one team — brand, engineering and operations together, the way the rest of Zorm works.

01

The Credibility Site

Your corporate site rebuilt as a diligence surface: the science story at two altitudes — expert and investor — team and track record, publications hub, and news discipline that makes momentum visible.

corporate sitetwo-altitude copypublications
02

The Pipeline Page, done right

Per-program, per-phase, honest about position, readable by a non-scientist, structured for AI engines — with an update workflow so it never rots. A stale pipeline page is diligence poison.

program × phaseupdate workflowstructured data
03

Investor & Partner Funnel

Segmented nurture for investor, partner and KOL tracks; a milestone announcement engine that hits site, email and LinkedIn in one push; data-room requests that don't leak.

segmented nurturemilestone enginedata-room flow
04

The Data Spine

One CRM as the source of truth: web, LinkedIn, email, webinars and conference badge scans all landing labeled by source, campaign and segment — with attribution a founder can read.

one CRMattributionlabeled leads
05

Conference Sprints

JPM Week, Biotech Showcase, BIO: the pre-week meeting funnel, on-site capture into the CRM the same day, and the 48-hour follow-up sequence that converts scans into meetings.

JPM · JanuaryBIO · June48-hr follow-up
06

AI-Answer Visibility

When an investor asks ChatGPT or Claude about your space, be the answer: entity graph, llms.txt, FAQ corpus and query-shaped pages. We run this practice on zorm.io itself — you are probably reading the proof.

AEOschema graphllms.txt
Fig. 04 · The flagship artifact

The pipeline page, the way diligence wants it.

Illustrative programs shown. Every row answers stage, indication framing and next milestone at a glance — expert detail one click deeper, and machine-readable underneath so AI engines quote it correctly instead of guessing.

FIG. 04A — bars mark phase position, not promises. The update workflow keeps position current; the structured-data layer keeps machines honest about it.

Fig. 05 · The differentiator

One spine. Every channel. Every lead labeled.

This is the part most agencies can't build and most biotechs never get: the data layer that turns marketing from a cost line into an instrument. Zorm builds data platforms for a living — the same muscle behind Sentinel's federal-data pipelines, pointed at your funnel.

Website inquiries
LinkedIn campaigns
Email & nurture
Webinars
Conference badge scans
Source of truth One CRM, labeled

source · campaign · segment · stage

Investor track
Partner / BD track
KOL track
Attribution you can read

PROOF IN PRACTICE — submit the form below and your inquiry lands in our CRM labeled BioTech, source-tagged to this page, with your stage on the record. We run the spine we sell.

Fig. 06 · Straight answers

What we are — and what we are not.

Life sciences is allergic to overreach, so here is the position stated plainly. Our proof is adjacent, not sector-native: six software platforms designed, built and still operated in-house; data pipelines over HUD, Census and BLS datasets running in production; and delivered work for conservative buyers including the Department of Defense, IAT Insurance and Yardi. The discipline transfers. The first life-science client gets a team with everything to prove.

Zorm is
  • One accountable team across brand, engineering and operations — no hand-offs
  • A product company: we ship and run our own software, not just decks
  • A data-engineering practice — pipelines, CRMs and attribution in production
  • Claims-disciplined: review-ready workflows your legal team can sign fast
Zorm is not
  • A med-comms or medical-affairs agency
  • A CRO, and not regulatory counsel — we never replace MLR or legal review
  • A healthcare ad network buying HCP media
  • Going to make a claim about your science. Ever.
Fig. 07 · The calendar is the funnel

Two seasons decide the year. Arrive with a machine.

January · San Francisco

JPM Week & Biotech Showcase sprint

The densest deal-making week in healthcare. We build the pre-week meeting-request funnel, the one-page company brief investors actually read, on-site capture into the CRM, and the 48-hour follow-up sequence — booked by November, live by New Year.

June · Rotating host city

BIO International sprint

Partnering-system chaos, tamed: your partnering profile, booth capture and post-event nurture wired into the same spine, so June's scans are still alive in September.

Fig. 08 · Questions, answered

What biotech teams ask us.

Do you work with preclinical companies?
Yes — preclinical and Series A/B companies are the core audience for this practice. At that stage the work is credibility infrastructure: a corporate site that survives investor diligence, a pipeline page that is honest and current, and the investor and partner funnel that makes momentum legible between raises.
Have you worked with biotech companies before?
We will say this plainly rather than imply otherwise: our proof is adjacent, not sector-native. Zorm has shipped and still operates six software platforms, built data pipelines over federal datasets, and delivered work for conservative, diligence-heavy buyers including the Department of Defense, IAT Insurance and Yardi. The discipline transfers; the first life-science client gets the benefit of a team with everything to prove.
Will you make claims about our science?
No. Zorm markets the company, never the molecule. Copy is built from your own published record — milestones, mechanisms as you have described them, team and process — and every deliverable ships with a review-ready workflow: versioned copy, claim-source traceability, and an approval trail your legal or MLR reviewers can sign off quickly. We make review fast; we never replace it.
What does a biotech website cost?
The same way everything at Zorm is priced: one fixed number quoted against a written scope, never hourly. A focused credibility-site engagement is quoted in weeks of work, not months; the site plus the data spine is the anchor engagement. Third-party costs pass through at cost.
Can you fix just our pipeline page?
Yes, and it is often the right first project. A pipeline page that is stale, vague about phase position, or unreadable to a non-scientist is diligence poison. We rebuild it as a per-program, per-phase surface with plain-language framing, an update workflow so it never rots, and structured data so AI engines quote it correctly.
What is the “data spine”?
One CRM as the source of truth for every channel you run: website inquiries, LinkedIn campaigns, email nurture, webinars, and conference badge scans all landing in one place — labeled by source, campaign and segment, with attribution reporting a founder can actually read. Inquiries from this page arrive in our own CRM labeled BioTech; we run the same spine we sell.
Can you run our JPM Week or BIO presence?
That is the conference sprint: the pre-week landing page and meeting-request funnel, on-site capture that lands scans in the CRM the same day, and the 48-hour follow-up sequence that converts contacts into meetings while everyone else is still flying home. Two seasons a year — January and June — and the funnel compounds between them.
Who owns the work?
You do — source code, design files, brand assets and the CRM data are delivered as owned assets. Zorm usually stays to operate what it builds because that arrangement works, not because anything is held hostage.
Fig. 09 · Start

Brief us. A human replies within one business day.

Five fields, no calendar link, no SDR sequence. Describe where you are and what has to be true at your next milestone — you'll get a reply with a point of view, including "you don't need us yet" when that's the honest answer.

Lands in our CRM labeled BioTech, source-tagged to this page — the same spine we build for clients.
Received — thank you. A human replies within one business day.

Business contact details only — used to reply to this inquiry, never resold. Prefer the general form? zorm.io/start.